Long Covid trials aim to clear lingering virus —and help patients in need
One Monday morning last September, Shelley Hayden pulled into a parking spot in an underground garage at the University of California San Francisco (UCSF). She switched off the ignition, pushed the red record button on her cellphone, and gazed into the camera. “The time has come,” said Hayden, long dark-blond hair framing her blue eyes. “Here we are, I’m actually getting to do something.”
More than 3 years earlier, in the summer of 2020, Hayden had come down with COVID-19 while visiting family in Colorado. Since then she’s been plagued by the disease’s cruel sequel, Long Covid, whose symptoms include ov...
Source: ScienceNOW - April 11, 2024 Category: Science Source Type: news
Dapivirine Vaginal Ring Safe, Effective at Preventing HIV During Pregnancy
THURSDAY, March 14, 2024 -- Adverse pregnancy outcomes related to use of the dapivirine vaginal ring (DVR) or daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) during the second trimester are uncommon, according to a study presented... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 14, 2024 Category: Pharmaceuticals Source Type: news
Strides Pharma gets USFDA nod to market HIV drug
The company's product is bioequivalent and therapeutically equivalent to Atripla Tablets of Gilead Sciences LLC, it added. As per per IQVIA, Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumurate tablet (EET) has a market opportunity of USD 7.5 million in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 4, 2023 Category: Pharmaceuticals Source Type: news
Expert Panel Recommends New Drugs for HIV Prevention
The “grade A” endorsement means that two additional drugs should be covered under the Affordable Care Act. (Source: NYT Health)
Source: NYT Health - August 22, 2023 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Acquired Immune Deficiency Syndrome Drugs (Pharmaceuticals) Preventive Medicine Sexually Transmitted Diseases Journal of the American Medical Assn Truvada (Drug) Descovy cabotegravir your-feed-science Source Type: news
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy
Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents show. (Source: NYT Health)
Source: NYT Health - July 22, 2023 Category: Consumer Health News Authors: Rebecca Robbins and Sheryl Gay Stolberg Tags: Acquired Immune Deficiency Syndrome Drugs (Pharmaceuticals) Inventions and Patents Suits and Litigation (Civil) Research Generic Brands and Products Gilead Sciences Inc Merck & Company Inc Truvada (Drug) Source Type: news
Gilead defeats U.S. government in big patent trial centered on HIV drugs
Pre-exposure prophylactic, or PrEP, use of the drugs Truvada and Descovy have been key to preventing HIV infections. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 9, 2023 Category: American Health Authors: Ron Leuty Source Type: news
U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs
Truvada is one of the drugs known as PrEP, a medication that has been shown to be highly effective at preventing the transmission of H.I.V. A jury sided with Gilead Sciences in a dispute over whether the government could claim a share of profits from drugs seen as crucial to ending the H.I.V.…#truvada #prep #gileadsciences #hiv #delaware #gilead #descovy #cdc #jeremiahjohnson #debtelman (Source: Reuters: Health)
Source: Reuters: Health - May 9, 2023 Category: Consumer Health News Source Type: news
Gilead Sciences didn't violate government patents on HIV prevention treatment, jury finds
The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. A Delaware jury on Tuesday cleared Gilead Sciences of U.S. government allegations that it violated patents held by the Centers for Disease and Prevention on an HIV prevention drug. The U.S.…#gileadsciences #oceanside #delaware #gilead #cdc #truvada #descovy #debtelman #hhs (Source: Reuters: Health)
Source: Reuters: Health - May 9, 2023 Category: Consumer Health News Source Type: news
Lupin gets tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide tablets
The tentative approval by the United States Food and Drug Administration (USFDA) has been granted under the President's emergency plan for AIDS relief (PEPFAR), Lupin said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 31, 2023 Category: Pharmaceuticals Source Type: news
HIV Prevention: New Injection Could Boost the Fight, But Some Hurdles Remain
This article is republished from The Conversation under a Creative Commons license. Read the original article. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - November 30, 2022 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Poverty & SDGs #HIV/Aids Source Type: news
A Switch to B/F/TAF Keeps HIV Suppressed, Even With Mutation A Switch to B/F/TAF Keeps HIV Suppressed, Even With Mutation
In people with suppressed HIV, including those with the M184V/I viral mutation, switching to combined bictegravir, emtricitabine, and tenofovir alafenamide has high efficacy, researchers report.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2022 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news
Government can't mandate coverage for drugs that prevent HIV infections, Texas federal judge rules
The lawsuit challenged a provision of the Affordable Care Act that required free coverage of the HIV drugs Truvada and Descovy, commonly known as PrEP, that thousands of Americans take. #truvada #descovy #affordablecareact (Source: Reuters: Health)
Source: Reuters: Health - September 7, 2022 Category: Consumer Health News Source Type: news
Truvada (Emtricitabine Tenofovir DF) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 16, 2022 Category: Drugs & Pharmacology Source Type: news
FDA Approves First Injection Regimen for HIV Prevention
Until now, two types of daily pills (Truvada and Descovy) were the only options for what's called pre-exposure prophylaxis (PrEP). (Source: WebMD Health)
Source: WebMD Health - December 21, 2021 Category: Consumer Health News Source Type: news
Cabotegravir Bests TDF-FTC for HIV Prevention in Those at Risk
THURSDAY, Aug. 12, 2021 -- For men who have sex with men (MSM) and transgender women, long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) is superior to tenofovir disoproxil fumarate-emtricitabine (TDF-FTC)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 12, 2021 Category: Pharmaceuticals Source Type: news
